✨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 76
5 MAY 2005
Manufacturers:
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Product:
Pegasys RBV (Combination Product)
Active Ingredient:
Peginterferon alfa-2a 360µg/mL
Dosage Form:
Solution for injection
Manufacturer:
F.Hoffman – La Roche AG, Basel, Switzerland
Active Ingredient:
Ribavirin 200mg
Dosage Form:
Film-coated tablet
Manufacturers:
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Product:
Roferon-A RBV (Combination Product)
Active Ingredient:
Interferon alfa-2a 30MIU/mL
Dosage Form:
Solution for injection
Manufacturers:
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada
Weimer Pharma GmbH, Rastatt, Germany
Active Ingredient:
Ribavirin 200mg
Dosage Form:
Film-coated tablet
Manufacturers:
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada
Weimer Pharma GmbH, Rastatt, Germany
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Product:
Roferon-A RBV (Combination Product)
Active Ingredient:
Interferon alfa-2a 6MIU/mL
Dosage Form:
Solution for injection
Manufacturers:
F.Hoffmann – La Roche Limited, Basel, Switzerland
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada
Active Ingredient:
Ribavirin 200mg
Dosage Form:
Film-coated tablet
Manufacturers:
F.Hoffmann – La Roche Limited, Basel, Switzerland
Hoffmann – La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Product:
Sensipar
Active Ingredient:
Cinacalcet hydrochloride 33mg
Dosage Form:
Film-coated tablet
New Zealand Sponsor:
Amgen Australia Pty Limited
Manufacturer:
Patheon Inc, Mississauga, Ontario, Canada
Product:
Sensipar
Active Ingredient:
Cinacalcet hydrochloride 66mg
Dosage Form:
Film-coated tablet
New Zealand Sponsor:
Amgen Australia Pty Limited
Manufacturer:
Patheon Inc, Mississauga, Ontario, Canada
Product:
Sensipar
Active Ingredient:
Cinacalcet hydrochloride 99mg
Dosage Form:
Film-coated tablet
New Zealand Sponsor:
Amgen Australia Pty Limited
Manufacturer:
Patheon Inc, Mississauga, Ontario, Canada
Dated this 26th day of April 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2628
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 76
Gazette.govt.nz —
NZ Gazette 2005, No 76
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare26 April 2005
Medicines, Distribution Consent, Medicines Act 1981
- DON MATHESON, Deputy Director-General, Public Health
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social WelfareMedicines, Distribution Consent, Medicines Act 1981